Clinical trial
A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium
NCT00309205 · International Partnership for Microbicides, Inc., Industry · Completed
Key facts
| NCT number | NCT00309205 |
|---|---|
| Title | A Safety Study of Dapivirine (TMC120) Vaginal Microbicide Gel in Belgium |
| Official title | A Phase I/II Single-Centre Double-Blinded Randomized Study of the Safety and Tolerability of TMC120 Vaginal Microbicide Gel vs. HEC-Based Universal Placebo Gel in Healthy HIV-Negative Women. |
| Lead sponsor | International Partnership for Microbicides, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV-1 |
| Intervention type | Drug |
| Interventions | dapivirine (TMC120) vaginal gel |
| Enrollment | 36 |
| Start date | Dec 1, 2005 |
| First posted | Mar 31, 2006 |
| Last update posted | Sep 1, 2009 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: